GFAP

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Study Overview The investigation into biomarkers for mild traumatic brain injury (mTBI) has garnered significant attention as the understanding of

Response to: Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase-L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account

Background on Biomarkers Biomarkers serve as vital indicators of biological processes, pathogenic processes, or pharmacologic responses to therapeutic interventions. In

Before glial fibrillary acidic protein and ubiquitin C-terminal hydrolase L1 can be recommended for identifying cerebral lesions in mild traumatic brain injury, all influencing factors must be taken into account Read Post »

Evaluation of GFAP, UCH-L1 and S100B Blood Biomarkers for the Management of Sports-Related Concussion in Professional Rugby Players: A Prospective Observational Study

Biomarkers in Sports-Related Concussion Sports-related concussions (SRC) pose significant challenges in diagnosis and management. Traditional evaluation methods, including clinical assessments

Evaluation of GFAP, UCH-L1 and S100B Blood Biomarkers for the Management of Sports-Related Concussion in Professional Rugby Players: A Prospective Observational Study Read Post »

Scroll to Top